WHY LFT DERANGED IN DENGUE

Liver Function Test (LFT) and Dengue Fever

Dengue fever, a mosquito-borne viral infection, is widely prevalent in tropical and subtropical regions. While it’s typically a self-limiting disease, it can escalate into severe dengue, characterized by complications like plasma leakage, hemorrhage, and organ dysfunction. Among these, the liver bears the brunt, often leading to deranged liver function test (LFT) results. Understanding this connection is crucial for effective patient management.

How Does Dengue Affect the Liver?

Dengue virus, upon entering the body, replicates rapidly, causing widespread infection. The liver, a vital organ responsible for various metabolic processes, filtration, and detoxification, is heavily impacted. The virus can directly invade hepatocytes, the functional units of the liver, leading to cellular damage. Additionally, the immune response triggered to combat the infection can cause collateral damage to liver cells. This dual attack results in the release of liver enzymes and other biochemical markers into the bloodstream, manifesting as abnormal LFT results.

Patterns of LFT Abnormalities in Dengue

The extent of LFT derangement in dengue varies, influenced by factors such as the severity of infection, individual immune response, and underlying liver health. Common patterns observed include:

1. Mild Elevation of Liver Enzymes:

In mild dengue cases, LFT abnormalities may be subtle. Modest elevations of liver enzymes, particularly alanine aminotransferase (ALT) and aspartate aminotransferase (AST), are often seen. These elevations typically resolve as the infection subsides.

2. Significant Liver Enzyme Elevation:

Severe dengue cases may exhibit significant LFT derangements. Marked elevations of ALT, AST, and bilirubin, along with prolonged prothrombin time (PT) and international normalized ratio (INR), are indicative of severe liver dysfunction. This pattern warrants prompt medical attention.

3. Cholestatic Pattern:

In some dengue cases, a cholestatic pattern of LFT abnormalities emerges. This is characterized by elevated alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and bilirubin, along with relatively normal or mildly elevated liver enzymes. This pattern may suggest involvement of the bile ducts or biliary obstruction.

Clinical Implications of LFT Derangement in Dengue

LFT abnormalities in dengue can have several implications:

1. Prognosis:

The degree of LFT derangement often correlates with the severity of dengue infection. More pronounced LFT abnormalities are associated with an increased risk of complications, including severe dengue, dengue shock syndrome, and even death.

2. Monitoring Disease Progression:

Serial LFT monitoring during the course of dengue infection allows clinicians to assess the disease’s progression and response to treatment. Worsening LFT parameters may indicate a worsening infection or complications, prompting appropriate interventions.

3. Identifying High-Risk Patients:

LFT derangements can help identify patients at high risk of developing severe dengue. Early recognition of these abnormalities enables proactive management, including closer monitoring, aggressive fluid resuscitation, and timely antiviral therapy, if indicated.

Management of LFT Derangement in Dengue

Currently, there is no specific antiviral treatment for dengue. Management focuses on supportive care, including:

1. Fluid Management:

Adequate fluid resuscitation is crucial to prevent dehydration and maintain organ perfusion. Intravenous fluids are typically administered to restore intravascular volume and prevent shock.

2. Antipyretics:

Fever control is essential to reduce discomfort and prevent complications. Medications like paracetamol (acetaminophen) are commonly used to manage fever in dengue.

3. Liver-Protective Agents:

In cases of severe LFT derangement, liver-protective agents like N-acetylcysteine (NAC) may be considered to support liver function and minimize further damage.

Conclusion

LFT derangement is a common manifestation of dengue infection, reflecting the impact of the virus on the liver. The extent of LFT abnormalities can vary and may provide insights into the severity of the infection and prognosis. Close monitoring of LFT parameters during dengue management is essential to identify high-risk patients, assess disease progression, and guide appropriate treatment strategies.

Frequently Asked Questions

1. Can dengue cause liver failure?

Yes, in severe cases, dengue can lead to fulminant hepatic failure, a life-threatening condition characterized by rapid deterioration of liver function.

2. What are the risk factors for severe LFT derangement in dengue?

Factors like older age, co-existing liver disease, obesity, and certain genetic predispositions may increase the risk of severe LFT abnormalities in dengue.

3. How long do LFT abnormalities in dengue typically persist?

LFT abnormalities in dengue usually resolve within a few weeks as the infection subsides. However, in severe cases, LFT derangements may persist longer or even progress to chronic liver disease.

4. Is there a specific treatment for LFT derangement in dengue?

Currently, there is no specific antiviral treatment for dengue. Management focuses on supportive care, including fluid resuscitation, fever control, and liver-protective agents.

5. How can LFT derangement in dengue be prevented?

Prevention of dengue infection is the key to preventing LFT derangement. Protective measures include using mosquito repellents, wearing protective clothing, and implementing mosquito control measures in endemic areas.